Ignite Creation Date:
2025-12-25 @ 2:45 AM
Ignite Modification Date:
2025-12-26 @ 1:25 AM
Study NCT ID:
NCT04802733
Status:
COMPLETED
Last Update Posted:
2024-11-01
First Post:
2021-03-12
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Phase 1 Safety and Tolerability Study of MSK-DA01 Cell Therapy for Advanced Parkinson's Disease
Sponsor:
BlueRock Therapeutics
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-05-03
Start Date Type:
ACTUAL
Primary Completion Date:
2023-05-18
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-06-10
Completion Date Type:
ACTUAL
First Submit Date:
2021-03-12
First Submit QC Date:
None
Study First Post Date:
2021-03-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-30
Last Update Post Date:
2024-11-01
Last Update Post Date Type:
ACTUAL